Clinical Efficacy Study of PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer | MicrobiomeTrials← Back to trialsNCT06561308
Clinical Efficacy Study of PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2025-09-01Est. Completion: 2027-12-01
Enrollment target: 39 participants Locations- Women's hospital school of medicine zhejiang university, Hangzhou, Zhejiang, China
Other microbiome trials you might be interested in
Endometrial CarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Dedifferentiated CarcinomaEndometrial Endometrioid AdenocarcinomaEndometrial Mixed Cell AdenocarcinomaEndometrial Serous AdenocarcinomaEndometrial Undifferentiated CarcinomaUterine Corpus Malignant Mixed Mesodermal (Mullerian) Tumor
This phase III trial tests whether adding trastuzumab and hyaluronidase-oysk (Herceptin Hylecta \[TM\]) or pertuzumab, t…
Birmingham, United StatesEst. completion Oct 31, 2027
Phase 2
Recruiting
Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial NeoplasiaFIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
This phase II trial studies whether adding tirzepatide injections to a levonorgestrel intrauterine device (LNG-IUD) impr…
Chicago, United StatesEst. completion Dec 31, 2028